Analysis of factors contributing to the efficiency of the in vitro production of transgenic goat embryos (Capra hircus) by handmade cloning (HMC)  by Pereira, A.F. et al.
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a  b  s  t  r  a  c  t
Cloning  by  Somatic  Cell  Nuclear  Transfer  (SCNT)  still  is challenging  and  inefﬁcient.  Recently,
the handmade  cloning  (HMC)  procedures  have  been  successfully  applied  to livestock
species.  The  aim of this  study  was  to  compare  the  effect  of distinct  oocyte  sources  (in vivo vs.
post-mortem)  and  the ﬁnal  cytoplasmic  embryo  volume  (∼85%  or 2 × 50%)  on  fusion  rates
and  on the developmental  potential  of Day-1  or Day-7  cloned  transgenic  goat  embryos
produced  by HMC  procedures.  Cloned  embryos  were  reconstructed  by HMC  using  skin
ﬁbroblast donor  cells  established  from  a  transgenic  goat.  Oocytes  were  obtained  in  vivo  by
laparoscopic  oocyte  recovery  (LOR)  from  hormonally  stimulated  females  or post-mortem
from slaughterhouse  ovaries  from  nonstimulated  goats,  resulting  in  no  differences  in the
number of  aspirated  follicles,  cumulus-oocyte  complexes  (COCs),  and  viable  COCs  per  goat.
However, the  COC  recovery  rate  was  higher  for  slaughterhouse  ovaries  (86.0%)  than  for
LOR (73.0%).  Also,  cytoplasmic  volume  (∼85%  vs. 2 × 50%)  had  no  effect  on  fusion  rates  after
embryo  reconstruction.  Using  slaughterhouse  ovaries  for  cloning,  a total  of  18.0%  (27/150)
and 12.7%  (19/150)  of  the  in  vitro-cultured  embryos  developed  to  the  compact  morula  and
blastocyst stages  on Day  7. However,  no  recipients  became  pregnant  on Day  30 following
the  transfer  of  Day-1  or Day-7  embryos.  In conclusion,  the  use of  slaughterhouse  ovaries
was as valuable  to supply  oocytes  for the  production  of  cloned  goat  embryos  by HMC  as the
in  vivo  approach.  The HMC  was  proven  a  simple  alternative  for  the  production  of cloned
transgenic  goat  embryos.. IntroductionAfter the birth of the ﬁrst cloned mammal  using adult
heep epithelial cells as donor nucleus (Wilmut et al.,
997), Somatic Cell Nuclear Transfer (SCNT) became a
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© 2012 Elsevier B.V. Open access under the Elsevier OA license.technology that has been successfully applied to more
than 20 animal species, including a range of livestock
species such as cattle (Cibelli et al., 1998), goats (Baguisi
et al., 1999), and pigs (Polejaeva et al., 2000). The use of
cloning has since been exploited to study interactions
 © 2012 Elsevier B.V. Open access under the Elsevier OA license.between the nucleus and the cytoplasm during differenti-
ation and to investigate the effects of SCNT on epigenetics
and nuclear reprogramming. Furthermore, SCNT has been
shown to have applications in the production of large-scale
inant Re164 A.F. Pereira et al. / Small Rum
numbers of genetically identical animals (Stice and Keefer,
1993), and also for genetic conservation (Campbell et al.,
2007). In addition, current advances in the production of
recombinant proteins have also had an important effect
on the pharmaceutical industry. In fact, a range of distinct
therapeutic proteins have been produced in the milk
of transgenic animals (Baguisi et al., 1999; Baldassarre
et al., 2004b),  making cloning one of the most important
supportive technologies for transgenesis.
Although SCNT is being performed in many laborato-
ries, successful application of the cloning technology is still
a difﬁcult and demanding task due to many factors, includ-
ing the stage of the donor cell cycle, the donor cell type,
the embryo culture system, imprinting defects and repro-
gramming failures, inefﬁcient embryo activation protocols,
lab-to-lab variation, and the oocyte source and quality at
the beginning of maturation (Campbell et al., 2005). Tra-
ditional SCNT animal cloning employs sophisticated pieces
of equipment, tailored micropipettes, and requires a high
level of technical skill. On the other hand, the handmade
cloning (HMC) procedures have been developed exactly
to circumvent the need of micromanipulators by using
zona-free oocytes (Peura et al., 1998; Vajta et al., 2001,
2003). The HMC  procedures are considered a technol-
ogy with equivalent efﬁciency to traditional SCNT cloning
(Tecirlioglu et al., 2005), indicating that it may  be read-
ily used as an alternative method for the generation of
cloned offspring in various animal species. In goats, sev-
eral studies on cloning have been successfully carried out
using either micromanipulation systems to produce zona-
intact (Baguisi et al., 1999; Lan et al., 2006) or zona-free
(Nasr-Esfahani et al., 2011) cloned embryos, or using the
non-micromanipulation (HMC) system for the production
of zona-free cloned embryos (Akshey et al., 2010). How-
ever, the optimization of the distinct steps in the cloning
procedures are still needed to attain a higher HMC  efﬁ-
ciency in the goat.
As a transgenic female goat founder was obtained
by pronuclear microinjection in 2008, which expressed
acceptable levels of the human Granulocyte Colony Stimu-
lating Factor (hG-CSF) in the milk (Freitas et al., 2012), our
current goal is to expand the herd by means of cloning pro-
cedures using the hG-CSF founder goat. Therefore, using
skin ﬁbroblast primary culture cells from the transgenic
founder goat as nucleus donor cells (karyoplasts), the aim
of this study was to optimize the HMC  cloning proce-
dure for the goat by the comparison of the effect of the
oocyte source (in vivo, from hormonally stimulated goats
vs. post-mortem, by using slaughterhouse ovaries from non-
stimulated females), and the ﬁnal cytoplasmic volume
schemes for embryo reconstruction (∼85% or 2 × 50%) on
fusion rates and on the in vitro and in vivo developmental
potential of Day-1 or Day-7 cloned transgenic goat embryos
obtained by HMC  procedures.
2. Materials and methods2.1. Animal care and biosafety
Animal use and care were approved by the Animal Ethics Committee
of  the Ceará State University (CEUA/UECE, no. 09144595-7/50), in compli-
ance with the Brazilian Biosafety Technical National Committee (CTNBio,search 109 (2013) 163– 172
no. 0288/06). Additionally, all trials were conducted in accordance with
the guidelines for animal care (ASAB, 2006).
2.2. Chemicals, reagents and media
Unless indicated otherwise, all chemicals and reagents were from
Sigma–Aldrich (St. Louis, USA) and the media for cell culture from Gibco-
BRL (Carlsbad, USA).
2.3. Experimental design
Two  independents experiments were carried out to compare the effect
of the source of oocytes as cytoplasts for cloning procedures, and to
evaluate the HMC  efﬁciency for the production of viable Day-1 or Day-
7 goat cloned embryos for the establishment of pregnancies following
transfers to female recipients, as described below. In Experiment 1, we
compared the efﬁciency between in vivo vs. post-mortem goat oocyte
retrieval systems by laparoscopy (LOR) or by the aspiration of slaugh-
terhouse ovaries, respectively. All oocytes obtained in this experiment
were used to optimize the HMC  cloning procedures to the goat. In Exper-
iment 2, using oocytes from slaughterhouse ovaries according to results
obtained from the ﬁrst experiment, we  evaluated the effect of the ﬁnal
cytoplasmic volume schemes (∼85 or 2 × 50%) on fusion rates. Addition-
ally, we observed the in vitro and in vivo developmental potential of
transgenic goat embryos cloned by HMC  and subsequently transferred
to  synchronous female recipients. During the study, we also character-
ized  qualitatively the somatic cell growth pattern of the ear ﬁbroblast
cells derived from the hG-CSF transgenic female goat by the analysis of
the  morphological cell features following the establishment of the cell
cultures.
2.4. Generation and establishment of somatic cell primary cultures
2.4.1. Establishment and expansion of primary cell cultures
Cell samples were derived from primary skin cell cultures following
standard procedures (Ribeiro et al., 2009). An ear biopsy was  asepti-
cally collected from an adult hG-CSF transgenic female Canindé founder
goat (Freitas et al., 2012). The ear tissue was diced into 2–3 mm pieces,
placed in 35-mm tissue culture dishes containing Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 0.22 mM sodium pyruvate,
26.2 mM sodium bicarbonate, 100 IU/mL penicillin G, 100 g/mL strepto-
mycin sulfate, 0.25 g/mL amphotericin B and 10% fetal calf serum (FCS),
and cultured for 7–14 days at 38.5 ◦C, 5% CO2 and high humidity until near
conﬂuence. Dermal ﬁbroblast-like cultures that reached 90% conﬂuence
were dispersed with a 0.25% trypsin/5 mM EDTA solution and subcultured
at a 1:3 ratio. All cell cultures were established, expanded and maintained
in culture until needed for analysis, or were cryopreserved in 0.25 mL  plas-
tic straws for further utilization, following established procedures (Urio
et  al., 2011).
2.4.2. Cell growth proﬁle
Frozen-thawed transgenic goat cells on the 3rd or 4th passages were
seeded in 4-well plates at cell densities of 1.0 ×104, 3 × 104, and 1.0 × 105
cells/well for the determination of the population doubling time (PDT).
Cells from two wells were trypsinized and counted at 24 h intervals for up
to 72 h of culture. The average cell counts at each time point were then
plotted against time, and the PDT was determined based on the obtained
cell growth proﬁle (Costa et al., 2005).
2.5. Oocyte source and in vitro maturation (IVM) – Experiment 1
The cumulus-oocyte complexes (COCs) used in this experiment were
recovered either in vivo from groups of superovulated live females, via
laparoscopic oocyte retrieval (LOR), or post-mortem from ovaries col-
lected from non-stimulated females at a local slaughterhouse. For the
LOR, the estrous cycle of groups of goats was synchronized using sponges
(Progespon, Syntex, Buenos Aires, Argentina) impregnated with 60 mg
medroxyprogesterone acetate (MAP) inserted intravaginally for 11 days.
On  day 8, a 50-g d-cloprostenol (Ciosin, Ford Dodge Saúde Animal,
Campinas, Brazil) injection was given intramuscularly (IM), along with
the onset of the ovarian stimulation, which was carried out using 120 mg
pFSH (Folltropin-V, Vetrepharm, Ontario, Canada) distributed in ﬁve IM
injections (30/30, 20/20 and 20 mg), 12 h apart. Animals were fasted for
24  h prior to the LOR, which was performed at the time of sponge removal,
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ccording to Pereira et al. (2012).  For the post-mortem oocyte retrieval,
varies from well fed goats were collected at a local slaughterhouse and
ransported to the laboratory in saline at 30 ◦C. For both retrieval systems
LOR and slaughterhouse), all follicles greater than 2 mm were counted
nd aspirated using an aspiration system proper for small ruminants
WTA, Cravinhos, Brazil).
Retrieved immature goat COCs from both oocyte retrieval groups
ere classiﬁed based on cellular vestments and cytoplasmic uniformity
Almeida et al., 2011). Only GI to GIII COCs were in vitro-matured in
CM199 supplemented with 0.022 g/mL sodium pyruvate, 10,000 IU
enicillin, 10,000 g/mL streptomycin sulfate, 25 g/mL amphotericin B,
0% FCS, 10 ng/mL EGF, 5 g/mL FSH, 10 g/mL LH, 1 g/mL 17-estradiol
nd 100 M cysteamine for 20 h at 38.5 ◦C, 5% CO2 and high humidity.
ollowing IVM, cumulus cells were removed by successive pipetting, and
atured oocytes (MII) with a ﬁrst polar body (PB) were selected for enu-
leation.
.6.  In vitro and in vivo development of cloned goat embryos by
andmade cloning (HMC) – Experiment 2
The preparation of recipient cytoplasts, donor cell cultures and
uclear transfer procedures by HMC  were adapted from procedures in
attle (Ribeiro et al., 2009; Gerger et al., 2010). The COCs for this experi-
ent were obtained from slaughterhouse ovaries and were subjected to
VM as already described above.
.6.1. Processing of IVM oocytes for preparation of cytoplasts
In  vitro-matured MII  oocytes were brieﬂy exposed to a 0.5% pro-
ease solution for zona pellucida removal, followed by a rinse in
ure FCS and multiple washes in holding medium (HM: TCM199 with
.022 g/mL sodium pyruvate, 10,000 IU penicillin, 10,000 g/mL strep-
omycin sulfate, 25 g/mL amphotericin B, 20% FCS). Zona-free oocytes
ere immediately used for SCNT. Brieﬂy, zona-free oocytes were hand-
isected in 2.5 g/mL cytochalasin B with a bisection blade (Ultra-Sharp
plitting Blades, Bioniche, USA) under a stereomicroscope. When the PB
as still attached to the oocyte, which indicates the probable location
f the MII  plate into the oocyte, only about 15% of the cytoplasm was
anually excised at the PB position, leaving a larger demi-oocyte with
pproximately 85% of its original cytoplasmic volume. In the absence of an
ttached PB, oocytes were bisected in halves of equal volumes (50%). Then,
emi-oocytes (50% and 85%) were screened under UV light in 10 g/mL
isbenzimide (Hoechst 33342) in HM for the selection of enucleated cyto-
lasts.
.6.2. Donor cell preparation for nuclear transfer
Ear ﬁbroblast cells derived from the hG-CSF transgenic goat were
sed as the donor cell for the production of cloned embryos, following
rocedures adapted from Ribeiro et al. (2009) and Gerger et al. (2010).
rozen-thawed cells at the 2nd or 3rd passages were thawed 2 days prior
o  cloning and were cultured so that a high conﬂuence level (>95%) could
e attained 12–24 h before their use as nucleus donor cells.
.6.3. Membrane fusion, chemical activation and in vitro embryo
ulture
After a brief exposure to a 500-g/mL phytohemoagglutinin solution,
loned embryos were reconstructed by the adhesion of either one demi-
ytoplast (∼85% cytoplasmic volume) or two hemi-cytoplasts (2 × 50%
ytoplasmic volume) to a single ﬁbroblast donor cell.
Reconstructed structures were electrofused by two 1.1-kV/cm DC
ulses for 5 s (∼26 h post-IVM), after a brief exposure to a 7.0-
 pre-fusion AC pulse in electrofusion medium (300 mM mannitol,
.1 mM MgSO4·7H2O, 0.05 mM CaCl2·2H2O, 0.5 mM HEPES, 0.01% PVA)
n  a 0.22-mm micro-fusion chamber (Micro chamber, Eppendorf, Ham-
urg, Germany) coupled to an electrofusion apparatus (Multiporator,
ppendorf, Hamburg, Germany). Fusion was assessed within 30–60 min.
used embryos were chemically activated 2–3 h post-fusion in 5 M
onomycin in HM for 5 min, followed by a 4 h incubation in 2 mM 6-
imethylaminopurine (6-DMAP) in modiﬁed SOFaa supplemented with
.4% BSA and 2% FCS. Resulting activated cloned embryos were in vitro-
ultured in 300 L modiﬁed SOFaa medium supplemented with 0.4% BSA
nd  2% FCS, under mineral oil. Cloned embryos were in vitro-cultured
IVC) individually in microwells using the well-of-the-well (WOW)  sys-
em, based on Vajta et al. (2000) and modiﬁed by Feltrin et al. (2006), atsearch 109 (2013) 163– 172 165
38.5 ◦C, in humidiﬁed air and 5% CO2, 5% O2 and 90% N2 for up to 24 h or
for 7 days of culture.
2.6.4. Zona free SCNT-embryo transfer
After up to 24 h of IVC, groups of transgenic cloned 1-cell stage goat
embryos were transferred into the oviducts of synchronous female recip-
ients on Day 1 of the estrous cycle, whereas other groups of transgenic
embryos were in vitro-cultured for up to 7 days to the morula and blasto-
cyst  stages prior to the uterine transfer to synchronous recipients, on Day 7
of the estrous cycle. Crossbreed goat recipients were estrus-synchronized
using intravaginal MAP-impregnated sponges for 10 days, associated with
an  injection of 400 IU eCG (Novormon, Syntex, Buenos Aires, Argentina)
and  75 g d-cloprostenol (Ciosin, Ford Dodge Saúde Animal, Campinas,
Brazil) at the 8th day of the protocol. Prior to the embryo transfer, the
recipient goats were fasted and anesthetized as described by Freitas et al.
(2007).  A laparoscopic examination was performed to conﬁrm the pres-
ence of at least one recent ovulation or corpus hemorragicum (CH) on Day
1 or a mature corpus luteum (CL) on Day 7, according to the day of the
embryo transfer. Day-1 cloned embryos were transferred into the oviduct,
whereas Day-7 cloned morulae/blastocysts were transferred into the uter-
ine horn, with the transfers being ipsilateral to the CH- or CL-bearing
ovary. Pregnancy diagnosis was performed per rectum by ultrasonogra-
phy on Days 28 and 35 of development, using a Falco 100 scanner (Pie
Medical, Maastricht, Netherlands) equipped with a transrectal 6–8 MHz
linear array transducer.
2.7. Data analyses
For Experiment 1, data regarding the mean number of follicles, total
COCs, and viable COCs, on a per female basis, and the recovery efﬁciency
(COCs per number of follicles) were analyzed using the Student’s t-test
or the 2 test, for P < 0.05. For Experiment 2, maturation and fusion rates
were compared by the 2 test (P < 0.05) and were evaluated for embryos
transferred both on Days 1 or 7. Cleavage and morula/blastocyst rates were
also compared by the 2 test (P < 0.05) and were obviously determined
only for embryos in vitro-cultured for 7 days and transferred on Day 7 of
development.
3. Results
3.1. In vitro growth pattern of the transgenic donor cells
Seven to 14 days after the tissue explants were placed
in culture plates, ﬁbroblastic cells were observed to out-
grow from the edges of the tissue pieces (Fig. 1A). Cells
showed typical ﬁbrous and fusiform morphologies with
centered oval-shaped nuclei (Fig. 1B), with the presence
of groups of isolated colonies of epithelial cells. Cells
then continued to proliferate and were subcultured up
to 90–95% conﬂuence (Fig. 1C). Fibroblasts grew rapidly
and gradually replaced the epithelial cells in subcultures.
After cryopreservation, transgenic cells presented the same
characteristics of the fresh cells during in vitro culture
(Fig. 1D). The growth kinetic of the transgenic cells was
demonstrated by counting total cells during 72 h of culture,
resulting in an estimated PDT of 23 h.
3.2. Retrieval efﬁciency of goat cumulus-oocyte
complexes obtained in vivo by laparoscopy (LOR) or
post-mortem from slaughterhouse ovaries
Data regarding COC retrieval after three sessions of LOR
performed in 36 hormonally stimulated donor females (12
females per session) and ﬁve replications with slaughter-
house ovaries from 63 nonstimulated goats (post-mortem
oocyte retrieval) are presented in Table 1. The mean num-
ber, per goat, of aspirated follicles (16.3 vs.16.3), total COCs
166 A.F. Pereira et al. / Small Ruminant Research 109 (2013) 163– 172
 ear exp
ervationFig. 1. Primary cultures of ear-derived goat tissue explants. (A) Edge of an
Fibroblast cells (B) at near conﬂuence, (C) at conﬂuence, prior to cryopres
(11.9 vs.14.0), and viable COCs (10.7 vs.11.4) did not differ
between the in vivo and the post-mortem groups. How-
ever, the COC recovery rate for slaughterhouse ovaries was
higher than for the LOR procedure (P < 0.05). When the
number of viable COCs was compared, based on the mor-
phological quality (Table 2), a signiﬁcant higher proportion
of COCs of better quality (Grade II, 63.2%) was obtained
in vivo by laparoscopy, from hormonally stimulated goats
(P < 0.05), than from slaughterhouse ovaries (post-mortem)
obtained from nonstimulated goats, which had a similar
Table 1
Comparison of the recovery efﬁciency of goat cumulus-oocyte complexes
(COCs) obtained in vivo by laparoscopy or post-mortem from slaughter-
house ovaries (mean ± SD) – Experiment 1.
Parameter COC retrieval by follicular
aspiration
In vivo (LOR) Post-mortem
No. of females 36 63
No. of aspirated follicles 588 1029
Mean (±SD) number of
aspirated follicles per goat
16.3 ± 0.2a 16.3 ± 3.4a
No. of recovered COCs oocytes 429 885
Mean (±SD) number of
recovered COCs per goat
11.9 ± 2.0a 14.0 ± 3.0a
COC recovery rate (%) 73.0a 86.0b
No. of viable COCs 385 720
Mean (±SD) number of viable
COCs per goat
10.7 ± 1.3a 11.4 ± 3.0a
a,b Numbers in the same row without common superscripts differ, P < 0.05.
LOR, laparoscopic oocyte recovery.lant, 7–14 days after the onset of culture, with ﬁbroblast cell outgrowth.
, and (D) 24 h in culture after thawing (200×).
proportion of Grades II and III COCs within the group (32.2
and 33.8%, respectively).
3.3. In vitro production of transgenic cloned goat
embryos and embryo transfer
After six replications, the mean COC recovery rate from
slaughterhouse goat ovaries (Fig. 2A) was 82.5% (Table 3),
and the maturation rate, based on PB selection (Fig. 2B and
C), was 83.2% (1046/1257). Selected COCs were used for the
production of cloned embryos that were in vitro-cultured
either for 1 day or for 7 days prior to transfer. No differences
were observed between the number of aspirated follicles,
COC recovery rate, morphological quality or maturation
rate between the sub-groups (Table 3).
Table 2
Total number of recovered oocytes and proportion of retrieved COCs based
on morphological quality following the follicular aspiration of goat ovaries
in  vivo by laparoscopy or post-mortem from slaughterhouse goat ovaries
– Experiment 1.
COC quality COC retrieval by follicular aspiration
In vivo (LOR) Post-mortem
n % n %
Grade I 74 17.2a 136 15.4a
Grade II 271 63.2a 285 32.2b
Grade III 40 9.3a 299 33.8b
Grade IV 42 9.8a 157 17.7a
Total 429 885
a,b Numbers in the same row without common superscripts differ, P < 0.05.
LOR, laparoscopic oocyte recovery.
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Fig. 2. In vitro production steps of goat handmade cloned embryos using donor cells from an hG-CSF transgenic goat. (A) Immature COCs from slaughterhouse
ovaries prior to IVM (200×). (B) COCs in modiﬁed HM after 20 h of IVM (200×). (C) In vitro-matured oocytes (MII) based on PB selection after the removal
of  cumulus cells (200×). (D) Zona-free oocyte after the enzymatic removal of the zona pellucida (600×). (E) Skin ﬁbroblast donor cells from a Canindé
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 microwell (400×). (H) Transgenic cloned blastocyst on Day 7 of develop
A total of 793 matured oocytes were submitted to
ona removal by protease digestion (Fig. 2D), with 85.1%
793/945) survival rate. Fibroblast donor cells in culture
ere in high conﬂuence (>95%) prior to use for cloning
Fig. 2E).
Results for in vitro and in vivo embryo developmen-
al potential are summarized in Table 4. A total of 139
nd 209 embryos were reconstructed for the transfers as
-cell stage embryos on Day 1 or as morulae/blastocysts
n Day 7, after 1 or 7 days of IVC, respectively. From
hose, 50 (36.0%) and 89 (64.0%), and 30 (14.4%) and 179
85.6%) embryos were reconstructed using ∼85% or 2 × 50%
nal cytoplasmic volume schemes for Day-1 or Day-7
mbryos, respectively. No differences were seen in fusion
ates between sub-groups, resulting in 30 (60.0%) and 79
89.0%), and 21 (70.0%) and 152 (85.0%) fused embryos with
85% or 2 × 50% of the ﬁnal cytoplasmic volumes for Day-
 or Day-7 embryos, respectively. Embryo types, based on
ytoplasmic volumes, were mixed for activation, initiated
7.5 h after the onset of the IVM.
For embryos that were in vitro-cultured for 7 days
rior to the transfers, cleavage rate on Day 2 (Fig. 2G)
able 3
umber of aspirated follicles, COC recovery rate and oocyte maturation rate for g
 Experiment 2.
IVC + ETa Ovaries Aspirated
follicles
Recovered COCs Oocyte quality 
I + II 
n n n % n % 
Day 1 + ET 50 374 349 93.3 168 48.1 
Day  7 + ET 111 981 914 93.2 355 38.8 
Total  161 1355 1263 93.2 523 41.4 
a IVC + ET: days in in vitro culture prior to the embryo transfer.nic 1-cell stage cloned embryo on Day 1 of IVC into a microwell (WOW
ell stage cloned embryo on Day 2 of IVC (evaluation of cleavage rate) into
ior to transfer to a synchronous female recipient (600×).
and morula and blastocyst rates on Day 7 were 87.3%,
18.0% and 12.7% (Fig. 2H), respectively, with the produc-
tion of 27 compact morulae and 19 blastocysts on Day 7
(46/171; 26.9%). For in vivo embryo development, a total
of 88 and 13 cloned transgenic 1-cell stage embryos and
Day-7 morulae/blastocysts were transferred into six syn-
chronous recipients, respectively. No recipients receiving
cloned embryos (Fig. 2F) were diagnosed pregnant upon
ultrasound examination on Days 28 and 35.
4. Discussion
The birth of live goat clones using different cell types
have been widely reported, including the birth of goats
using primary fetal somatic cell line derived from a trans-
genic female fetus (Baguisi et al., 1999), dwarf goats cloned
using fetal ﬁbroblast cells (Keefer et al., 2001), dairy goats
using cumulus and fetal ﬁbroblast cells (Lan et al., 2006),
BELE (Breed Early, Lactate Early) goats cloned using adult
granulosa cells (Keefer et al., 2002), and Asian Yellow goats
cloned using ear ﬁbroblast cells (Chen et al., 2007). The
knowledge of the donor nucleus cell lineage or type in use
oat COCs obtained from slaughterhouse ovaries used for cloning by HMC
IVM rate
III IV Immature
oocytes
MII  oocytes
n % n % n n %
111 31.8 24 6.9 321 268 83.5
421 46.1 138 15.1 907 710 78.3
532 42.1 162 12.8 1257 1046 83.2
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Table 4
In vitro embryo development of hG-CSF (human Granulocyte Colony Stimulating Factor) transgenic goat embryos produced by handmade cloning (HMC),
and  number of embryos transferred per synchronous female recipient – Experiment 2.
IVC + ET Reconstructed
embryos
Fusion rateA Embryos per total
MII  oocytes
Cleavage rateB Morulae rateC Blastocyst rateC ET
n n % n % n % n % n % n/recipient
Day 1 + ET 139 109 78.4 109/268 40.7a – – – – – – 88/5
Day  7 + ET 209 173 82.8 171/710 24.1b 131/150 87.3 27/150 18.0 19/150 12.7 13/1D
Total 348 282 81.0 282/1046 27.0 131/150 87.3 27/150 18.0 19/150 12.7 101/6
a,b Numbers in the same column without common superscripts differ, P < 0.05.
A Fusion of either one demi-cytoplast (85%) + donor cell or two hemi-cytoplasts (2 × 50%) + donor cell (see text for details).
B Assessment on Day 2 of development.
C Assessment on Day 7 of development.
D Transfer of seven compact morulae and six blastocysts.
for cloning are considered by many investigators as a key
factor needed to increase nuclear reprogramming compe-
tence and, in turn, the cloning efﬁciency. In fact, several
studies have proposed over the years the need of the syn-
chronization/arrest of the cell cycle in the G0/G1 phase
(Akshey et al., 2011; Choresca et al., 2009; Koo et al., 2009)
or the evaluation of the competence of other donor cells
other than ﬁbroblasts from adult or fetal origin (Dutta et al.,
2011). In our work, we also veriﬁed the growth proﬁle of
somatic cells from a transgenic goat. To date, studies on
cell culture conditions and cell cycle synchronization from
transgenic goats are rather limited (Memili et al., 2004). A
standard analysis of the phenotype and PDT for ear ﬁbro-
blast cells from an hG-CSF transgenic goat was performed
in this study, demonstrating the cells’ potential to be used
as donor cells in our SCNT program. For that, cells were
synchronized by contact inhibition through high conﬂu-
ence, leading to the successful in vitro production of cloned
embryos by HMC. Even though we have not analyzed the
cell cycle stage to verify the cell synchrony prior to cloning
in this study, our results agree, at least in part, with ﬁnd-
ings by Boquest et al. (1999) in which more than 85% of
cells were in G0/G1 when from highly conﬂuent cultures
(>95%), and by Gerger et al. (2010),  who demonstrated
a linear increase in blastocyst yield and a positive cor-
relation between the in vitro developmental potential of
HMC-derived cloned bovine embryos and the level of cell
culture conﬂuence at or near the plateau phase prior to
cloning.
Thus far, several transgenic and non-transgenic live
born goats have been produced by conventional cloning
using micromanipulators (Baguisi et al., 1999; Behboodi
et al., 2004; Keefer et al., 2002; Lan et al., 2006), and
recently, a cloned goat have been produced (Nasr-Esfahani
et al., 2011) using the simpliﬁed zona-free method pro-
posed by Oback et al. (2003) in cattle. Even though in vitro
(Akshey et al., 2008, 2010, 2011; Feltrin et al., 2012) and
in vivo (Feltrin et al., 2012) embryo development has been
attained in goats using the HMC  procedures, results on the
birth of HMC-derived goats are yet to be achieved. A few
factors may  contribute to the slower technological devel-
opment of alternative cloning procedures in goats when
compared with cattle, including the lower availability of
good quality oocytes, and the less extensive knowledge of
the cell biology, physiology, and manipulations and strictculture requirements for goat in vitro embryo production
(Baldassarre et al., 2004a; Behboodi et al., 2004). Such fac-
tors delay the development of alternative procedures, as for
cloning by HMC, with the discussion of technical results on
the establishment of successful protocols being important
for future studies.
The easy access to an abundant and inexpensive source
of properly matured oocytes is one of the limiting factors
in the commercial application of SCNT in farm animals
(Baldassarre et al., 2004a).  Although cloned transgenic
goats have been produced using oocytes collected from
hormonally stimulated donor animals (Baguisi et al., 1999),
abattoir-derived ovaries is still a great and inexpensive
source of oocytes for the production of transgenic cloned
goats, and may  be more cost effective for the genera-
tion of pharmaceutically important proteins. In general,
abattoir oocytes may  be easier to obtain and more cost
effective than maintaining and stimulating a herd of donor
goats. In turn, laparoscopic procedure for the aspiration
of follicle from hormonally stimulated females has been
proposed as an efﬁcient method for the exponential prop-
agation of goats of high genetic value (Cognie et al.,
2004). In this study, we  demonstrated that, on one hand,
the in vivo approach resulted in higher quality oocytes,
whereas on the other hand, a higher oocyte recovery rate
was  obtained from slaughterhouse ovaries. Nevertheless,
both laparoscopic and aspiration of slaughterhouse ovaries
were effective as sources of good quality oocytes for goat
SCNT trials.
Reggio et al. (2001) demonstrated no signiﬁcant differ-
ences in the percentage of matured oocytes successfully
enucleated and reconstructed using oocytes from FSH-
stimulated females vs. abattoir-derived ovaries. In the
same study, the COC source had also no effect on embryo
development and overall pregnancy rate. In our study, no
differences in number of aspirated follicles, total retrieved
COCs and viable COCs were seen between hormonally stim-
ulated females subjected to laparoscopic in vivo follicular
aspiration and slaughterhouse ovaries from nonstimulated
females, which contrasted results by Reggio et al. (2001),
who  obtained an average of 24.4 and 1.6 oocytes per
female from the superstimulated and nonstimulated ani-
mal  groups, respectively. Interestingly, higher recovery
efﬁciency was  obtained from slaughterhouse ovaries in
this study, which was  likely due to a stricter control over
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he follicular aspiration process than the remote laparo-
copic approach. Also, visually undetected follicles may  be
spirated when controlled by hand, improving the recov-
ry efﬁciency. Despite the lower recovery efﬁciency, the
n vivo aspiration of superstimulated goats resulted in a
igher proportion of good quality oocytes. Likely, the hor-
onal stimulation provided better conditions for follicular
evelopment, resulting in COCs with improved quality
han in the case of nonstimulated females (Sirard et al.,
006). However, to be effective, the laparoscopic in vivo
ocyte retrieval requires speciﬁc instrumentation, highly
rained personnel, and usually, hormonal stimulation of the
onor females, which makes the procedure more laborious,
xpensive and less cost effective than the use of slaughter-
ouse ovaries.
To be suitable for the goat, the HMC  procedure requires
peciﬁc adaptations in its steps (Nasr-Esfahani et al., 2011).
ere, we also observed that zona-free oocyte and embryo
anipulations presented singular conditions in goats when
ompared with cattle. When placed in in vitro matura-
ion, immature oocytes from different livestock species
re known to take different time periods to reach the
etaphase II stage. In the present study, oocytes used for
loning by HMC  were matured for 20 h before being pro-
essed for cloning. In general, the IVM process requires
 period of around 24 h for its completion, although in
oats, a slightly longer period of 27 h has been observed
Cognie et al., 2004). Meanwhile, in our cloning procedures,
he beginning of embryonic reconstruction started usually
0–21 h after IVM so that embryonic activation could occur
round 27 h after then onset of IVM. Consequently, the
eriod of oocyte/zygote manipulation in this work was car-
ied out within the window of biological viability already
eported for the goat.
The enzymatic digestion is considered the method of
hoice in domestic livestock species for the removal of
he zona pellucida. Interestingly, we observed that goat
ocytes appeared to be more sensitive to protease diges-
ion, when compared with our previous experience in cattle
Ribeiro et al., 2009; Gerger et al., 2010). Consequently, in
he present study, we used enzymatic digestion with pro-
ease at a concentration of 0.25%, differently of the 0.5%
oncentration used for bovine oocytes (Gerger et al., 2010;
ajta et al., 2004). In another study with goat oocytes,
asr-Esfahani et al. (2011),  observed that 0.25% protease
n the presence of 10% serum in medium was ideal for zona
emoval after 1 min  incubation, after evaluating the pro-
ease concentration in a range from 1 to 5 mg/mL  (0.1–0.5%)
or the zona removal. Moreover, using the 0.25% protease
olution, oocytes with enlarged but not completely dis-
olved zonae were released from the zona by pipetting
ith a narrow bored pipette. Additionally, we also used the
ame concentration of protease as Akshey et al. (2010) for
ona-free goat embryos. Rates of survival following zona
igestion and rates of development to the morula and blas-
ocyst stages reﬂected well the effectiveness of the lower
oncentration of protease used in this study.The presence of an attached PB on the zona-free oocyte
s very useful as a guide for the removal of a smaller amount
f cytoplasm from the oocyte, adjacent to the PB, during
anual enucleation. Using procedures adapted from cattlesearch 109 (2013) 163– 172 169
(Ribeiro et al., 2009), the manual section of goat oocytes
resulted in 82 demi-cytoplasts and 231 hemi-cytoplasts
(with ∼85% and ∼50% of the cytoplasmic volume) out of
648 matured oocytes. Thus, the PB-oriented bisection that
results in ∼85% cytoplasts improved the embryo yield after
cloning by HMC  (especially in the Group Day 1 + ET, as pre-
sented in Table 4), rendering it advantageous for species
such as the goat, for which oocyte supply and numbers are
usually limiting factors. However, the reduction in cyto-
plasmic volume, even if minimal, may have a detrimental
effect on further embryo development, as demonstrated
by others in cattle (Peura et al., 1998; Westhusin et al.,
1996; Ribeiro et al., 2009). Nevertheless, oftentimes the
PB detaches from zona-free oocytes during the manipu-
lation for the zona removal. Consequently, such oocytes
must be bisected in two  similar halves, unless alternative
approaches are applied to minimize the loss of cytoplasm.
In some species, such as in mice and cattle, the use of
chemical supplements in the medium, like sucrose and
demecolcine, is helpful for the appearance of a clear pro-
trusion cone on the oocyte surface in the region next to the
MII  plate (Vajta et al., 2001).
The in vitro culture (IVC) conditions have a crucial
impact on the development not only of in vitro-fertilized
but also of SCNT-derived embryos (McEvoy, 2003). Several
culture systems, such as the WOW  system (Vajta et al.,
2001), agarose gel (Peura and Vajta, 2003), ﬂat surface
(Akshey et al., 2010), and microdrops (Oback et al., 2003)
have been developed for the IVC of zona-free embryos,
with a signiﬁcant variation in terms of blastocyst produc-
tion efﬁciency. The WOW  system is an effective approach
to culture zona-free embryos, as it provides a constant
in vitro microenvironment due to its suitable size surround-
ing the embryo, also avoiding the formation of chimeras
when direct contact between individual zona-free embryos
occurs (Du et al., 2007). In cattle, a blastocyst yield of about
50% was observed using the WOW  system (Vajta, 2007),
which clearly demonstrates its efﬁciency for the IVC of
zona-free cloned embryos. Moreover, the lack of zona pel-
lucida as a result of HMC  procedures does not affect either
the development to blastocysts (Rodríguez et al., 2008) or
the birth of cloned bovine, swine and mice (Vajta et al.,
2004; Ribas et al., 2005; Du et al., 2007). Using a modiﬁed
WOW  system, goat blastocyst rates observed in this study
were equivalent to results obtained by Akshey et al. (2010)
in goats (12.7% vs. 15.8%, respectively). Dutta et al. (2011),
using adult ﬁbroblast cells, and Feltrin et al. (2012),  using
ﬁbroblasts and bone marrow-derived mesenchyimal stem
cells from adult lysozyme transgenic goats, obtained cloned
blastocyst rates of around 30% by the HMC  procedure. On
other hand, in preliminary experiments, parthenogenetic
morula/blastocyst rate of 21.1% was  obtained using goat
oocytes with zona pellucida activated chemically (unpub-
lished data).
Pregnancies and live born goats have been reported by
cloning using conventional (Baguisi et al., 1999; Keefer
et al., 2002; Behboodi et al., 2004) and zona-free SCNT
(Nasr-Esfahani et al., 2011) procedures, as previously
described. To produce live cloned goats, reconstructed
embryos must be transferred into the oviduct or the uterus
of synchronous recipients. For the intrauterine transfer,
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embryos must be in further stages of development, which
can be attained either by the transient in vivo culture
into the oviducts of a host female (Wilmut et al., 1997),
which is usually unpractical, or after the IVC in the lab-
oratory. The IVC of cloned embryos is one of the most
important stages affecting the preimplantation develop-
ment, pregnancy and the number of offspring generated
(Campbell et al., 2007). Although cloned goat embryos can
develop to the blastocyst stage after IVC, there are only few
births of live kids following the transfer of in vitro-cultured
cloned blastocysts (Nasr-Esfahani et al., 2011). Ohkoshi
et al. (2003) produced the ﬁrst SCNT-derived cloned goat
following the transfer of in vitro-produced blastocysts, and
despite the lower efﬁciency, Tang et al. (2011) conﬁrmed
that in vitro-cultured SCNT goat blastocysts can develop
to term. However, studies regarding an optimal embryo
culture system for goat embryos are still pending. To the
current knowledge, most of the viable cloned goats have
been derived from the transfer of early stage embryos to
the oviduct of recipients. Most viable cloned goats were
derived from 1- to 4-cell stage embryos when transferred
to the oviducts of recipients, with 7–10 cloned embryos
transferred to each oviduct; pregnancy rates on Days 30–50
ranged from 17 to 50%, depending on the type of donor
cells, oocyte origin, and culture conditions (Keefer et al.,
2001, 2002; Behboodi et al., 2005; Lan et al., 2006). In this
light, the number of goat embryos transferred per female
seems to affect the survival rate of embryos in cloning
programs (Liu et al., 2011). The increase in the number
of transferred embryos may  be beneﬁcial for producing
more live offspring with fewer recipients (20–30 cloned
embryos per recipient) in goat cloning (Liu et al., 2011).
Reggio et al. (2001) produced ﬁve transgenic cloned goats,
using an average of eight 2- to 4-cell stage embryos/female
(ranging from 1 to 15 embryos/female). In the limited trial
carried out in our study, we also analyzed the in vivo devel-
opmental competence of cloned embryos by the transfer
of a mean number of 17.6 zona-free 1-cell stage HMC-
derived embryos and 13 cloned morulae/blastocyts per
synchronous female recipients, resulting in no detected
pregnancies by ultrasonography.
Even though no recipients receiving reconstructed
cloned 1-cell stage goat embryos became pregnant in this
study, and as only a few replications with morula and blas-
tocyst transfers were performed, the negative results may
be more related to the low number of transfers performed
and to factors unrelated to the zona-free condition of
the transferred embryos. Zona-free blastocysts have been
extensively and successfully transferred in cattle (Peura
et al., 1998; Oback et al., 2003; Vajta et al., 2004), pigs (Du
et al., 2007), and even goats (Nasr-Esfahani et al., 2011),
resulting in live born animals. However, a current dogma
in developmental biology postulates that the transfer of
embryos into the oviducts at early stages requires the pres-
ence of the zona pellucida or similar protective barrier, such
as agar embedding, for the protection of embryos from the
recipient’s immune system (Loi et al., 1999). One of the
main limitations of the zona-free method, then, would be
the fragility of the zona-free oocyte and early embryos,
and the requirement that embryos have to reach at least
the compact morula or early blastocyst stages in vitro tosearch 109 (2013) 163– 172
avoid disintegration or an immune system attack in the
oviduct without the protective layer of the zona pellucida
(Du et al., 2005; Vajta et al., 2005). Considering that no preg-
nancies were obtained in this study following the transfer
of HMC-derived embryos, and taking the factors above
into consideration, it is feasible to consider that the trans-
fers of zona-free 1-cell stage embryos into the oviducts
were expected to result in failure. However, a similar study
carried out in pigs to evaluate the in vivo developmental
viability of porcine handmade cloned embryos showed that
the transfer of zona-free 1-cell stage embryos directly into
the oviduct of a synchronous sow, without zona pellucida
or agar embedding, can in fact result in a positive pregnancy
outcome (Ohlweiler et al., 2010). However, such possibility
still needs to be tested in other species, such as the goat.
In summary, skin-derived somatic cells from an hG-CSF
transgenic goat were successfully used as karyoplasts for
the in vitro production of cloned embryos by HMC  proce-
dures. Also, despite the lower COC recovery efﬁciency, our
preliminary results indicated that the in vivo laparoscopic
procedure was as efﬁcient as the use of slaughterhouse
ovaries for the retrieval of goat COCs, with both methods
rendering a similar number of good quality oocytes, on
a per goat basis. Nevertheless, the use of slaughterhouse
ovaries from nonstimulated goat females appeared to be as
effective to provide oocytes for use as cytoplasts for cloning
as the in vivo laparoscopic approach from hormonally stim-
ulated females, making the former a more advantageous
procedure than the latter due to its simplicity and rather
inexpensive outcome. Further studies are still underway for
the production of live born offspring by HMC  procedures in
goats.
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